Home LiteratureArticle Details
PMID: 10331434 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism.

Journal of neuropathology and experimental neurology ·Vol. 58 ·No. 5 ·1999-05-00 ·Pages 459-71

Martin LJ

Abstract

The mechanisms for neurodegeneration in amyotrophic lateral sclerosis (ALS) are not understood. We found that motor neuron degeneration in ALS structurally resembles apoptosis. The progression of neuronal death is divisible into 3 sequential stages: chromatolysis, somatodendritic attrition, and apoptosis. In ALS spinal cord anterior horn and motor cortex, DNA fragmentation is detectable in situ and in gels and is internucleosomal, occurring in the presence of DNA fragmentation factor-45/40 activation and increased caspase-3 activity. By immunoblotting, changes occur in the subcellular distribution of cell death proteins that would promote apoptosis. In selectively vulnerable CNS regions in ALS compared with controls, the proapoptotic proteins Bax and Bak are elevated in the mitochondrial-enriched membrane compartment, but are reduced or unchanged in the cytosol. In contrast, the antiapoptotic protein Bcl-2 is decreased in the mitochondrial-enriched membrane compartment of vulnerable regions in ALS, but is increased in the cytosol, whereas Bcl-xL levels are unchanged in both subcellular compartments. Coimmunoprecipitation experiments showed that Bax-Bax interactions are greater in the mitochondrial-enriched membrane compartment of ALS motor cortex compared with controls, whereas Bax-Bcl-2 interactions are lower in the membrane compartment of ALS motor cortex compared with controls. We conclude that a PCD mechanism, involving cytosol-to-membrane and membrane-to-cytosol redistribution of cell death proteins and caspase-3 activation, participates in the pathogenesis of ALS.

MeSH Terms
Adult Aged Amyotrophic Lateral Sclerosis/pathology Apoptosis/physiology Caspase 3 Caspases/metabolism Cell Nucleus/pathology DNA Fragmentation Deoxyribonucleases/analysis Female Humans Immunoblotting In Situ Nick-End Labeling Male Membrane Proteins/analysis Middle Aged Mitochondria/enzymology Motor Neurons/chemistry,cytology,enzymology Nerve Degeneration/enzymology,pathology Poly-ADP-Ribose Binding Proteins Precipitin Tests Proto-Oncogene Proteins/analysis Proto-Oncogene Proteins c-bcl-2 Subcellular Fractions/chemistry,enzymology bcl-2 Homologous Antagonist-Killer Protein bcl-2-Associated X Protein
Chemicals
BAK1 protein, human BAX protein, human Membrane Proteins Poly-ADP-Ribose Binding Proteins Proto-Oncogene Proteins Proto-Oncogene Proteins c-bcl-2 bcl-2 Homologous Antagonist-Killer Protein bcl-2-Associated X Protein DFFB protein, human Deoxyribonucleases CASP3 protein, human Caspase 3 Caspases
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Martin L J
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196, USA.
Article Info
Journal
Journal of neuropathology and experimental neurology
Abbr.
J Neuropathol Exp Neurol
ISSN
0022-3069
Published
1999-05-00
Pages
459-71
Language
English
Region
England
NLM ID
2985192R
Subset
IM
Grants
NINDS NIH HHS · NS 34100 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com